Key Points
Australia is now the first country to allow psychiatrists to prescribe certain psychedelic substances to patients with depression or post-traumatic stress disorder...
Psilocybin, the psychoactive ingredient in psychedelic mushrooms, can be given to people who have hard-to-treat depression..
Psychedelics researchers have benefited from federal grants, including Johns Hopkins, and the FDA released draft guidance late last month for researchers designing clinical trials testing psychedelic drugs as potential treatments for a variety of medical conditions...
And medical experts in the U.S. and elsewhere, Australia included, have cautioned that more research is needed on the drugs efficacy and the extent of the risks of psychedelics, which can cause hallucinations...
There are concerns that evidence remains inadequate and moving to clinical service is premature; that incompetent or poorly equipped clinicians could flood the space; that treatment will be unaffordable for most; that formal oversight of training, treatment, and patient outcomes will be minimal or ill-informed, said Dr. Paul Liknaitzky, head of Monash Universitys Clinical Psychedelic Lab...
You might be interested in
‘Groundbreaking’: New drugs treating cancer in patients with other cure; Here’s all you need to know
14, Aug, 23At the Christie hospital in Manchester, medical professionals are currently overseeing approximately 30 clinical trials. Encouragingly, they are observing that around two-thirds of patients with blood cancer, who have exhausted all other treatment possibilities, are showing positive responses to the administered drugs.
Explained | Can psychedelics treat depression? A doctor explains.
30, Apr, 23Can psychedelic drugs create lasting positive changes in brain function? The Hindu explains the potential benefits of their use in treating depression. Subscribe now to read the full article.